1. 管辖权
ORI对于在美国境外实施的NIH项目是否有管辖权？
肖传国在中国所进行的临床试验是否属于NIH项目的一部分？如果不属于NIH项目，那么，肖传国回国后，或NYU在24 May 2005发表2例结果后，用NIH 2.5M资金的剩余部分做了什么？

http://www.globalforumhealth.org/Media-Publications/Archive-RealHealthNews/Interviews/Chinese-neurologist-straddles-two-boats
Chinese neurologist "straddles two boats"
by Jie Gao (March 05)
2005
Xiao formally returned to China in 1997. ...with the approval of the US National Institutes of Health, he also took along with him his complete laboratory, worth US$1 million...

http://www.urotoday.com/264/conference_reports/selected_abstracts/female_urology__part_10.html
24 May 2005
CREATION OF A SOMATIC-AUTONOMIC REFLEX PATHWAY FOR TREATMENT OF NEUROGENIC BLADDER IN PATIENTS WITH SPINAL CORD INJURY: PRELIMINARY RESULTS OF FIRST 2 USA PATIENTS
Christopher E Kelly*, Chuan-Guo Xiao, Howard Weiner, Aleksandar Beric, Victor W Nitti, Herbert Lepor, New York, NY

http://projectreporter.nih.gov/project_info_description.cfm?aid=6698512&icde=2639225
Project Number:      5R01DK053063-05      Principal Investigator(s):      XIAO, CHUAN-GUO
Title:     SKIN-CNS-BLADDER REFLEX ARC FOR MICTURITION AFTER SCI     Awardee Organization:     NEW YORK UNIVERSITY SCHOOL OF MEDICINE

Project End Date:     31-DEC-2007
Budget End Date:     31-DEC-2007

RESULTS
Title (Link to full-text in PubMed Central)      Journal (Link to PubMed abstract)      Authors     Related Publications     Cited By
Reinnervation for neurogenic bladder: historic review and introduction of a somatic-autonomic reflex pathway procedure for patients with spinal cord injury or spina bifida.     European Urology.. 2006 Jan; 49 (1) :22-8; discussion 28-9

Xiao CG. Reinnervation for neurogenic bladder: historic review and introduction of a somatic-autonomic reflex pathway procedure for patients with spinal cord injury or spina bifida. Eur Urol. 2006 Jan;49(1):22-8; discussion 28-9. Epub 2005 Nov 2.
Acknowledgments
Supported by grants from: ... NIH (R01 DK44877 and R01 DK53063).

2. 具体案例
2.1 美国方面，
"The preliminary results of the pilot studies described in the applications ..."
The pilot studies at Beaumont虽然不是NIH资助的，但显然是其申请NIH资金的基础，而此pilot studies基于false information and suspicious data.

The key data of the trial, such as the success rate and the occurrence rate of the complications, can be traced back to Dr. Xiao's unpublished report [12] (see "How Xiao Procedure Trials Started in U.S." http://xysblogs.org/xysergroup/archives/7065). The trial was also believed to be based on false information regarding the acceptance of the procedure in China, which was exposed by Dr. Xiao when he was interviewed by the meida [13] and was confirmed by Dr. Wise Young on the CareCure forums [14].